Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
66.2M
-
Shares change
-
+1.9M
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
+$86.2M
-
Put/Call ratio
-
0
-
Number of buys
-
103
-
Number of sells
-
-112
-
Price
-
$44.76
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2014
245 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2014.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.2M shares
of 71.9M outstanding shares and own 91.95% of the company stock.
Largest 10 shareholders include Neuberger Berman Group LLC (5.52M shares), VANGUARD GROUP INC (5.31M shares), FRANKLIN RESOURCES INC (4.44M shares), BlackRock Fund Advisors (3.62M shares), State Street Corp (3.21M shares), BAMCO INC /NY/ (2.47M shares), KALMAR INVESTMENTS INC /DE/ (2.33M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.97M shares), BlackRock Institutional Trust Company, N.A. (1.74M shares), and ROYAL BANK OF CANADA (1.59M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.